Global Recombinant Collagen Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Recombinant Collagen Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Recombinant collagen, as a substitute for natural animal tissue collagen, has the potential to be widely used in fields such as biomaterials and biomedicine. A wide variety of recombinant collagen types and their derivatives can be industrialized on a certain scale in various expression systems.
Recombinant Collagen report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Recombinant Collagen market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Food Health Care and Beauty Cosmetics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Recombinant Collagen industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Recombinant Collagen key manufacturers include Giant Biogene Holding, Avantor, ProColl, Merck, ACROBiosystems, Wuhan Fine Biotech, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu Jland Biotech and Jiangsu Trautec Medical Technology, etc. Giant Biogene Holding, Avantor, ProColl are top 3 players and held % sales share in total in 2022.
Recombinant Collagen can be divided into Recombinant Type I Collagen, Recombinant Type III Collagen and Recombinant Type XVII Collagen,, etc. Recombinant Type I Collagen is the mainstream product in the market, accounting for % sales share globally in 2022.
Recombinant Collagen is widely used in various fields, such as Food Health Care, Beauty Cosmetics and Biomedical Materials,, etc. Food Health Care provides greatest supports to the Recombinant Collagen industry development. In 2022, global % sales of Recombinant Collagen went into Food Health Care filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Recombinant Collagen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Giant Biogene Holding
Avantor
ProColl
Merck
ACROBiosystems
Wuhan Fine Biotech
Shanxi Jinbo Bio-Pharmaceutical
Jiangsu Jland Biotech
Jiangsu Trautec Medical Technology
OriGene Technologies
Segment by Type
Recombinant Type I Collagen
Recombinant Type III Collagen
Recombinant Type XVII Collagen
Food Health Care
Beauty Cosmetics
Biomedical Materials
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Recombinant Collagen market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Recombinant Collagen, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Recombinant Collagen industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Recombinant Collagen in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Recombinant Collagen introduction, etc. Recombinant Collagen Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Recombinant Collagen market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Recombinant Collagen report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Recombinant Collagen market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Food Health Care and Beauty Cosmetics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Recombinant Collagen industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Recombinant Collagen key manufacturers include Giant Biogene Holding, Avantor, ProColl, Merck, ACROBiosystems, Wuhan Fine Biotech, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu Jland Biotech and Jiangsu Trautec Medical Technology, etc. Giant Biogene Holding, Avantor, ProColl are top 3 players and held % sales share in total in 2022.
Recombinant Collagen can be divided into Recombinant Type I Collagen, Recombinant Type III Collagen and Recombinant Type XVII Collagen,, etc. Recombinant Type I Collagen is the mainstream product in the market, accounting for % sales share globally in 2022.
Recombinant Collagen is widely used in various fields, such as Food Health Care, Beauty Cosmetics and Biomedical Materials,, etc. Food Health Care provides greatest supports to the Recombinant Collagen industry development. In 2022, global % sales of Recombinant Collagen went into Food Health Care filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Recombinant Collagen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Giant Biogene Holding
Avantor
ProColl
Merck
ACROBiosystems
Wuhan Fine Biotech
Shanxi Jinbo Bio-Pharmaceutical
Jiangsu Jland Biotech
Jiangsu Trautec Medical Technology
OriGene Technologies
Segment by Type
Recombinant Type I Collagen
Recombinant Type III Collagen
Recombinant Type XVII Collagen
Segment by Application
Food Health Care
Beauty Cosmetics
Biomedical Materials
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Recombinant Collagen market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Recombinant Collagen, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Recombinant Collagen industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Recombinant Collagen in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Recombinant Collagen introduction, etc. Recombinant Collagen Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Recombinant Collagen market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices